drugset / Trial / NCT06433362
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, single arm, multicenter study to evaluate the safety and efficacy of CMOEP in patients with untreated peripheral T-cell lymphoma.
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 750 mg/m2 | — |
| Subject | Etoposide | Small molecule | 60 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 18 mg/m2 | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Vincristine | Small molecule | 1.4 mg/m2 | Intravenous |
| Subject | Vindesine | Small molecule | 3 mg/m2 | — |